In patients with central serous chorioretinopathy, eyes treated with intravitreal bevacizumab injections and which achieved complete resolution of subretinal fluid have a 50% chance of CSC recurrence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results